Safety of RSV Preventive Monoclonal Antibody
Public ClinicalTrials.gov record NCT07158814. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Safety of Simultaneous Administration of Respiratory Syncytial Virus (RSV) Preventive Monoclonal Antibody With Routine Childhood Immunizations in Infants
Study identification
- NCT ID
- NCT07158814
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 4
- Lead sponsor
- Duke University
- Other
- Enrollment
- 524 participants
Conditions and interventions
Conditions
Interventions
- Respiratory Syncytial Virus (RSV) Preventive Monoclonal Antibody Drug
Drug
Eligibility (public fields only)
- Age range
- 6 Weeks to 30 Weeks
- Sex
- All
- Healthy volunteers
- Not listed
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 1, 2025
- Primary completion
- Jan 31, 2027
- Completion
- Mar 31, 2027
- Last update posted
- Mar 15, 2026
2025 – 2027
United States locations
- U.S. sites
- 6
- U.S. states
- 5
- U.S. cities
- 5
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Kaiser Permanente Northern California | Oakland | California | 94612 | Recruiting |
| Emory University | Atlanta | Georgia | 30322 | Recruiting |
| Centers for Disease Control and Prevention | Atlanta | Georgia | 30333 | Active, not recruiting |
| Columbia University | New York | New York | 10027 | Recruiting |
| Duke University | Durham | North Carolina | 27710 | Recruiting |
| Cincinnati Children's Hospital Medical Center | Cincinnati | Ohio | 45229 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07158814, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 15, 2026 · Synced Apr 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07158814 live on ClinicalTrials.gov.